Association between Polymorphisms in Glutathione Peroxidase and Selenoprotein P Genes, Glutathione Peroxidase Activity, HRT Use and Breast Cancer Risk

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Méplan, Catherine ^a   Dragsted, Lars Ove ^b   Ravn Haren, Gitte ^b,c   Tjønneland, Anne ^d   Vogel, Ulla ^e   Hesketh, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^e NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLUTATHIONE PEROXIDASE; SELENOPROTEIN P;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG USE; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GPX1 GENE; GPX4 GENE; HETEROZYGOSITY; HOMOZYGOSITY; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; ONCOGENE; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SEPP1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOD2 GENE; TUMOR CLASSIFICATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENOTYPE; GLUTATHIONE PEROXIDASE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SELENOPROTEIN P; SUPEROXIDE DISMUTASE;

EID: 84883809996     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073316     Document Type: Article

References (57)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Campeau PM, Foulkes WD, Tischkowitz MD, (2008) Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 124: 31-42.
3. Vera-Ramirez L, Ramirez-Tortosa MC, Sanchez-Rovira P, Ramirez-Tortosa CL, Granados-Principal S, et al. (2013) Impact of diet on breast cancer risk: a review of experimental and observational studies. Crit Rev Food Sci Nutr 53: 49-75.
4. Meindl A, Ditsch N, Kast K, Rhiem K, Schmutzler RK, (2011) Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. Dtsch Arztebl Int 108: 323-330.
5. Loft S, Poulsen HE, (1996) Cancer risk and oxidative DNA damage in man. J Mol Med (Berl) 74: 297-312.
6. Ambrosone CB, (2000) Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2: 903-917.
7. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, et al. (2005) No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 2459-2461.
8. Riscuta G, Dumitrescu RG, (2012) Nutrigenomics: implications for breast and colon cancer prevention. Methods Mol Biol 863: 343-358.
9. Knight JA, Onay UV, Wells S, Li H, Shi EJ, et al. (2004) Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 13: 146-149.
10. Ravn-Haren G, Olsen A, Tjonneland A, Dragsted LO, Nexo BA, et al. (2006) Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27: 820-825.
11. Bellinger FP, Raman AV, Reeves MA, Berry MJ, (2009) Regulation and function of selenoproteins in human disease. Biochem J 422: 11-22.
12. Charalabopoulos K, Kotsalos A, Batistatou A, Charalabopoulos A, Vezyraki P, et al. (2006) Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA. Br J Cancer 95: 674-676.
13. Lopez-Saez JB, Senra-Varela A, Pousa-Estevez L, (2003) Selenium in breast cancer. Oncology 64: 227-231.
14. Brigelius-Flohe R, Kipp A, (2009) Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta 1790: 1555-1568.
15. Saito Y, Sato N, Hirashima M, Takebe G, Nagasawa S, et al. (2004) Domain structure of bi-functional selenoprotein P. Biochem J. 381: 841-846.
16. Forsberg L, de Faire U, Marklund SL, Andersson PM, Stegmayr B, et al. (2000) Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol Dis 26: 423-426.
17. Hu YJ, Diamond AM, (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63: 3347-3351.
18. Hesketh J, Meplan C, (2011) Transcriptomics and functional genetic polymorphisms as biomarkers of micronutrient function: focus on selenium as an exemplar. Proc Nutr Soc 70: 365-373.
19. Meplan C, Crosley LK, Nicol F, Horgan GW, Mathers JC, et al. (2008) Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. Am J Clin Nutr 87: 1019-1027.
20. Villette S, Kyle JA, Brown KM, Pickard K, Milne JS, et al. (2002) A novel single nucleotide polymorphism in the 3′ untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol Dis 29: 174-178.
21. Meplan C, Crosley LK, Nicol F, Beckett GJ, Howie AF, et al. (2007) Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). Faseb J 21: 3063-3074.
22. Meplan C, Nicol F, Burtle BT, Crosley LK, Arthur JR, et al. (2009) Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status. Antioxid Redox Signal 11: 2631-2640.
23. Cooper ML, Adami HO, Gronberg H, Wiklund F, Green FR, et al. (2008) Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res 68: 10171-10177.
24. Meplan C, Hughes DJ, Pardini B, Naccarati A, Soucek P, et al. (2010) Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 31: 1074-1079.
25. Steinbrecher A, Meplan C, Hesketh J, Schomburg L, Endermann T, et al. (2010) Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev 19: 2958-2968.
26. Udler M, Maia AT, Cebrian A, Brown C, Greenberg D, et al. (2007) Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer. J Clin Oncol 25: 3015-3023.
27. Cox DG, Hankinson SE, Kraft P, Hunter DJ, (2004) No association between GPX1 Pro198Leu and breast cancer risk. Cancer Epidemiol Biomarkers Prev 13: 1821-1822.
28. Cox DG, Tamimi RM, Hunter DJ, (2006) Gene x Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study. BMC Cancer 6: 217.
29. Tsai SM, Wu SH, Hou MF, Chen YL, Ma H, et al. (2012) Oxidative stress-related enzyme gene polymorphisms and susceptibility to breast cancer in non-smoking, non-alcohol-consuming Taiwanese women: a case-control study. Ann Clin Biochem 49: 152-158.
30. Bermano G, Smyth E, Goua M, Heys SD, Wahle KW, (2010) Impaired expression of glutathione peroxidase-4 gene in peripheral blood mononuclear cells: a biomarker of increased breast cancer risk. Cancer Biomark 7: 39-46.
31. Tjonneland A, Christensen J, Thomsen BL, Olsen A, Stripp C, et al. (2004) Lifetime alcohol consumption and postmenopausal breast cancer rate in Denmark: a prospective cohort study. J Nutr 134: 173-178.
32. Benzon Larsen S, Vogel U, Christensen J, Hansen RD, Wallin H, et al. (2010) Interaction between ADH1C Arg(272)Gln and alcohol intake in relation to breast cancer risk suggests that ethanol is the causal factor in alcohol related breast cancer. Cancer Lett 295: 191-197.
33. Petersen RK, Larsen SB, Jensen DM, Christensen J, Olsen A, et al. (2012) PPARgamma-PGC-1alpha activity is determinant of alcohol related breast cancer. Cancer Lett 315: 59-68.
34. Vogel U, Christensen J, Nexo BA, Wallin H, Friis S, et al. (2007) Peroxisome proliferator-activated receptor-gamma2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis 28: 427-434.
35. Vogel U, Nexo BA, Olsen A, Thomsen B, Jacobsen NR, et al. (2003) No association between OGG1 Ser326Cys polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12: 170-171.
36. Elston CW, Ellis IO, (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410.
37. Miller SA, Dykes DD, Polesky HF, (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
38. Ratnasinghe D, Tangrea JA, Andersen MR, Barrett MJ, Virtamo J, et al. (2000) Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 60: 6381-6383.
39. Wang J, Shete S, (2011) Testing Hardy-Weinberg proportions in a frequency-matched case-control genetic association study. PLoS ONE 6: e27642.
40. Burk RF, Hill KE, (2009) Selenoprotein P-Expression, functions, and roles in mammals. Biochim Biophys Acta 1790: 1441-1447.
41. Jablonska E, Gromadzinska J, Reszka E, Wasowicz W, Sobala W, et al. (2009) Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur J Nutr 48: 383-386.
42. Hansen RD, Krath BN, Frederiksen K, Tjonneland A, Overvad K, et al. (2009) GPX1 Pro(198)Leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer. Mutat Res 664: 13-19.
43. Mobley JA, Brueggemeier RW, (2004) Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis 25: 3-9.
44. Hu J, Zhou GW, Wang N, Wang YJ, (2010) GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 124: 425-431.
45. Hu Y, Benya RV, Carroll RE, Diamond AM, (2005) Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J Nutr 135: 3021S-3024S.
46. Peng S, Lu B, Ruan W, Zhu Y, Sheng H, et al. (2011) Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Res Treat 127: 309-324.
47. Rayman MP, (2002) The argument for increasing selenium intake. Proc Nutr Soc 61: 203-215.
48. Serra-Majem L, Pfrimer K, Doreste-Alonso J, Ribas-Barba L, Sanchez-Villegas A, et al. (2009) Dietary assessment methods for intakes of iron, calcium, selenium, zinc and iodine. Br J Nutr 102Suppl 1: S38-55.
49. Easton DF, Eeles RA, (2008) Genome-wide association studies in cancer. Hum Mol Genet 17: R109-115.
50. Terry MB, Gammon MD, Zhang FF, Knight JA, Wang Q, et al. (2006) ADH3 genotype, alcohol intake and breast cancer risk. Carcinogenesis 27: 840-847.
51. (2007) World Cancer Research Fund/American Institute for CancerResearch, Washington,DC. Available: http://www.dietandcancerreport.org/cancer_resource_center/er_full_report_english.php. Accessed 2013 Jul 31.
52. Yager JD, Liehr JG, (1996) Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36: 203-232.
53. Roy D, Liehr JG, (1989) Changes in activities of free radical detoxifying enzymes in kidneys of male Syrian hamsters treated with estradiol. Cancer Res 49: 1475-1480.
54. Yager JD (2000) Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr: 67-73.
55. Ha EJ, Smith AM, (2003) Plasma selenium and plasma and erythrocyte glutathione peroxidase activity increase with estrogen during the menstrual cycle. J Am Coll Nutr 22: 43-51.
56. Zhou X, Smith AM, Failla ML, Hill KE, Yu Z, (2012) Estrogen status alters tissue distribution and metabolism of selenium in female rats. J Nutr Biochem 23: 532-538.
57. Crawford A, Fassett RG, Geraghty DP, Kunde DA, Ball MJ, et al. (2012) Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 501: 89-103.